Lifestyle
- Regular physical activity
- Weight management
- Stress reduction
- Adequate sleep
Seek immediate medical attention if FBG is below 2.8 mmol/L or above 13.9 mmol/L.
Fasting Blood Glucose · Nüchternblutzucker · FBG · Blutzucker
Fasting Blood Glucose measures the concentration of glucose in the blood after an overnight fast.
Fasting required; ranges may vary slightly by age and sex.
Fasting Blood Glucose (FBG), also known as Nüchternglukose, is a critical biomarker used to measure the concentration of glucose in the blood after a period of fasting, typically 8-12 hours. This test is fundamental in assessing the body's ability to regulate glucose, a primary energy source for cellular functions. Researchers have found that FBG levels reflect the efficiency of insulin-mediated glucose uptake and hepatic glucose production. Clinically, FBG is pivotal in diagnosing and monitoring diabetes mellitus, a condition characterized by chronic hyperglycemia. Elevated FBG levels are indicative of impaired glucose metabolism, often associated with insulin resistance, metabolic syndrome, and increased risk for cardiovascular diseases. Conversely, low FBG levels may suggest hypoglycemia, which can occur due to excessive insulin or other metabolic disorders. In the context of athletic performance and biohacking, maintaining optimal FBG levels is crucial for energy management and metabolic flexibility. Biohackers often monitor FBG to optimize metabolic health and longevity, aiming to prevent insulin resistance and its associated complications. However, researchers have observed that FBG levels can be influenced by various factors, including stress, illness, and recent physical activity. Therefore, fasting is required to obtain accurate measurements, and results should be interpreted considering these potential confounders.
Klinische Bedeutung
Elevated FBG levels indicate potential diabetes mellitus or impaired glucose tolerance, while low levels may suggest hypoglycemia. Consistently high FBG is associated with increased risk for cardiovascular diseases and peripheral neuropathy.
Progressively rising FBG values suggest worsening glucose tolerance or diabetes; retest in 3 months.
Falling FBG values may indicate improved glucose control or risk of hypoglycemia.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any supplementation, especially if on medication.
Draw blood in the morning after an overnight fast for consistency.
Testing Frequency
Annually for healthy adults, more frequently if diabetic or at risk.
Correlated with
Current research suggests that reference ranges and optimal targets for fasting blood glucose in diagnosing peripheral neuropathy and related conditions remain debated, particularly concerning confounders like age and sex. Researchers have not yet established standardized cutoffs for fasting blood glucose in diverse populations, which may affect diagnostic accuracy. Unanswered clinical questions include the precise role of fasting blood glucose in predicting long-term complications in patients with diabetes and its relationship with other biomarkers in assessing neuropathy risk.
1,575
Total Citations
14
Human/RCT
15.0
Avg. Influence
2026
Latest
Researchers found that the HbA1c test is a reliable biomarker for diagnosing and prognosing diabetes, reflecting long-term glycemic control. The study highlighted its correlation with the risk of diabetes complications and its potential as a substitute for fasting blood glucose.
This study examined the evaluation and differential diagnosis of peripheral neuropathy, a common neurologic issue. Researchers found that diabetes, nerve compression, and nutritional deficiencies are common causes. They emphasized the importance of comprehensive laboratory testing, including fasting blood glucose, for accurate diagnosis.
Researchers reviewed the effects of histidine supplementation on glucose homeostasis and found that it may improve fasting blood glucose levels. However, they noted that high doses could lead to adverse effects, indicating a need for further research.
This review examined the triglyceride-glucose index as a biomarker for insulin resistance and related disorders. Researchers found that fasting blood glucose and triglycerides are key components in calculating the TyG index, which is linked to various health conditions.
This report discussed the dual role of serum ferritin as both an iron status measure and an inflammatory biomarker. Researchers suggested optimal ferritin levels could improve health outcomes, similar to fasting blood glucose adjustments.
Researchers analyzed fasting blood glucose levels across various diseases, finding significantly increased levels in 57 out of 64 diseases studied. The findings suggest that elevated fasting blood glucose may be a common pathophysiological characteristic of these conditions.
This review focused on hepatogenous diabetes, which develops in patients with chronic liver disease. Researchers observed that it is associated with impaired glucose tolerance and higher risks of complications compared to normoglycemic patients.
In this study, researchers evaluated serum SIRT1 levels as a potential biomarker for early Alzheimer's diagnosis. They found significantly lower levels in Alzheimer's patients compared to controls, indicating its diagnostic promise.
This study evaluated laboratory tests in patients with spasmodic dysphonia. Researchers found elevated levels of various biomarkers, including fasting blood glucose, which may help in diagnosing underlying conditions.
In this case report, researchers found a 71-year-old female with low HbA1c despite high fasting blood glucose due to cold agglutinin interference. They suggested that alternative glycemic control measures may be beneficial in similar cases.
Research publications about Nüchternglukose over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer